UWorld Pharmacology Practice Test

Sulfonylureas lower blood sugar levels primarily by stimulating insulin secretion from pancreatic beta cells. These medications bind to specific receptors on the surface of beta cells in the pancreas, which leads to the closure of ATP-sensitive potassium channels. This action causes the depolarization of the beta cell membrane, opening voltage-gated calcium channels and resulting in an influx of calcium ions. The increase in intracellular calcium concentration triggers the release of pre-formed insulin into the bloodstream. By enhancing insulin secretion, sulfonylureas not only reduce blood glucose levels directly but also improve the overall efficiency of glucose metabolism in the body, particularly in response to meals. This mechanism is particularly beneficial for patients with type 2 diabetes, whose pancreatic beta cells may still be capable of insulin production but require a stimulus to secrete it effectively. The other options involve mechanisms that do not align with the action of sulfonylureas. Increasing glucose uptake in muscles and inhibiting intestinal glucose absorption are mechanisms related to other classes of diabetic medications, while promoting gluconeogenesis would actually raise blood glucose levels rather than lower them. Thus, the correct answer focuses on the primary role of sulfonylureas in directly promoting insulin secretion.